Keros Therapeutics, Inc. (KROS): SC 13G filed Apr 11, 2022

Form type

SC 13G

Filing date

Apr 11, 2022

Accession number

0001178913-22-001487

Filer

Keros Therapeutics, Inc. (CIK 1664710)